Nexalin Technology Announces Publication Of Fourth Peer-Reviewed Article Reporting Results From Clinical Research On 15 mA DIFS Technology In Alzheimer's Disease
Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer's Disease, a recognized international peer-reviewed journalStatistically significant improvement in
Scientists published research showing Nexalin's device helped Alzheimer's patients in a test. When real doctors approve studies like this, it hints the company's idea might work.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.